Scott Boyes

Chairman, Chief Executive Officer and President

Scott Boyes is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management.

Beth Stavola

Chief Operating Officer and Director

Beth Stavola is also the Founder and CEO of Stavola Medical Marijuana Holdings, Health for Life Inc, GreenMart of Nevada, and CBD For Life, thriving cannabis businesses that process, grow and dispense throughout locations in both Arizona and Nevada. Before entering the cannabis space, Beth was Senior Vice President of Institutional Equity Sales at Jefferies New York.

Randy Stafford


Randy has extensive experience in finance & operations, centered in the Financial services, real estate and nutraceutical sectors. He has previously served as the CFO of the MPX Bioceutical Corporation and has experienced first handed the evolution of the company. He is presently self-employed and is a CPA, CMA along with a MBA from the University of Toronto.

Andrew R. Ryan


Andrew Ryan has been General Counsel and a member of the Executive Committee at Holtec International since 2014.

Andrew is responsible for all legal matters affecting Holtec and its subsidiaries as well as insurance and risk management oversight, regulatory compliance, human resources and corporate administration. Prior to joining the executive team of Holtec, Mr. Ryan was an attorney with Lauletta Birnbaum, LLC.

Senator Richard S. "Tick" Segerblom


Senator Tick Segerblom, State Senator of the Nevada State Senate since November 2012, is widely recognized as a leading legislator in Nevada, and the United States, in the medical and recreational marijuana fields.

Senator Segerblom, age 69, authored Nevada's 2013 Medical Marijuana law and was Co-Chair of the successful 2016 ballot initiative campaign which approved recreational marijuana in the state.

Robert R. Galvin


Robert Galvin has been CFO and Senior VP of Finance and Administration at Holtec International, an energy technology company, since 2016.

Prior to joining Holtec, Robert served as CFO of several companies, including NuCO2, a NASDAQ company providing bulk CO2 equipment and services. Mr. Galvin is experienced with mergers & acquisitions, debt and equity financings, and SEC compliance. He is a CPA, a Director and Audit Chair for OneSource Water, and a Director and former Stewardship Chair for the New Jersey Juvenile Diabetes Research Foundation.

Miles D. Thompson, Ph.D.


Dr. Thompson, Ph.D., Project Scientist at Department of Pediatrics, University of San Diego, California since 2016, will advise and assist with the development of cannabinoid-based nutraceutical products. Dr. Thompson served as a Clinical Research Associate at North York General Hospital in Toronto and initiated the study of cannabinoids in epilepsy at the Department of Pharmacology and Toxicology at the University of Toronto. He has extensive experience in the design and implementation of clinical trials administered by Health Canada.

Robert Petch


Mr. Petch has 30 + years of senior management, strategic planning and financial analysis experience, including both buy-side and sell-side capital markets experience.

Mr. Petch spent 15 years at Dresdner Kleinwort Benson advising companies on strategy and fundraising including leading a number of successful IPOs, acquisitions and disposals.

Mr. Petch is a Chartered Accountant, and has an honours degree in Engineering Science from Oxford University.